Epidermolysis bullosa simplex 3, basal, autosomal recessive, with bp230 deficiency Q82.8

Last updated on: 09.01.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Autosomal recessive, mild to moderate, monogenic epidermolysis bullosa simplex-1D (EBS3) with basal cleft formation, is associated with a mutation in the DST (BPAG1) gene (113810) on chromosome 6p12. EBS3 is a very rare (only single families with <20 affected individuals have been described to date) skin disorder characterized by traumatic blistering that usually resolves without scarring or with only mildly atrophic scars. The severity varies; in some patients, the disease occurs locally with preferential involvement of the hands and feet. In others, the blistering may be generalized. In some patients, the condition improves with age.

LocalizationThis section has been translated automatically.

Blistering occurs mainly on the feet and ankles.

Clinical featuresThis section has been translated automatically.

Groves et al (2010) reported on a 38-year-old Kuwaiti man with a lifetime history of trauma-related spontaneous blisters and erosions, particularly affecting his ankles and feet. Evidence included nail dystrophies. Rarely, erosions also affected the face, trunk, and proximal limbs. The blisters and erosions healed without scarring. No mucosal involvement. No milia formation. No alopecia; hair status normal.

Liu et al (2012) reported on a 34-year-old Iranian woman with lifelong skin blistering that worsened in summer and after trauma, such as clothing friction points. The blistering occurred mainly on the ankles, feet, dorsal sides of the hands, and elbows. Discrete scarring. Hair, nails, mucous membranes, or genitalia were not affected. Otherwise, no other abnormalities.

HistologyThis section has been translated automatically.

Histology shows cleavage at the level of basal keratinocytes (Hovnanian et al. 1993; Jonkman et al.1996).

EM: Electron microscopic examination of the skin showed cleavage within the basal keratinocytes. Furthermore, discrete abnormalities of hemidesmosomes with poorly formed inner plaques can be seen (Liu et al. (2012).

IF: No evidence of BP-230 at the dermal-epidermal interface and in keratinocytes. Possible decreased immunoreactivity for beta-4 integrin (ITGB4; 147557), PLEC1 (601282), and COL17A1 (113811).

LiteratureThis section has been translated automatically.

  1. Fine JD et al (2008) The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on diagnosis and classification of EB. J Am Acad Derm 58: 931-950.
  2. Ganani D et al. (2021) Epidermolysis bullosa simplex due to bi-allelic DST mutations: case series and review of the literature. Pediatr Dermatol 38: 436-441.
  3. Groves R W et al. (2010) A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J Invest Derm 130: 1551-1557.
  4. Liu L et al (2012) Autosomal recessive epidermolysis bullosa simplex due to loss of BPAG1-e expression. (Letter) J Invest Derm 132: 742-744.
  5. Takeichi Tet al. (2015) Founder mutation in dystonin-e underlying autosomal recessive epidermolysis bullosa simplex in Kuwait. Br J Dermatol 172:527-531.
  6. Wen D et al (2021) Localized autosomal recessive epidermolysis bullosa simplex arising from a novel homozygous frameshift mutation in DST (BPAG1). Clin Exp Dermatol doi: 10.1111/ced.14917.

Last updated on: 09.01.2022